Like many fictional characters, the mad scientist figure has its basis in real life.
medical
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Researchers identify gene associated with lupus
The gene, NCF1, was known by researchers, but it had not previously been linked to lupus
Hearst Foundations make grant to OMRF
OMRF has received a $200,000 grant to grow its cancer research programs.
OMRF adds two to its board
The semiannual board meeting was held on Wednesday.
OMRF earns top rating from Charity Navigator
OMRF was one of 24 Oklahoma charities to receive the highest designation.
